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Abstract
Background: Apoptosis is a common and essential aspect of development. It is particularly prevalent in the
central nervous system and during remodelling processes such as formation of the digits and in amphibian
metamorphosis. Apoptosis, which is dependent upon a balance between pro- and anti-apoptotic factors, also
enables the embryo to rid itself of cells damaged by gamma irradiation. In this study, the roles of the anti-apoptotic
factor Bcl-xL in protecting cells from apoptosis were examined in Xenopus laevis embryos using transgenesis to
overexpress the XR11 gene, which encodes Bcl-xL. The effects on developmental, thyroid hormone-induced and
γ-radiation-induced apoptosis in embryos were examined in these transgenic animals.
Results: Apoptosis was abrogated in XR11 transgenic embryos. However, the transgene did not prevent the
apoptotic response of tadpoles to thyroid hormone during metamorphosis. Post-metamorphic XR11 frogs were
reared to sexual maturity, thus allowing us to produce second-generation embryos and enabling us to distinguish
between the maternal and zygotic contributions of Bcl-xL to the γ-radiation apoptotic response. Wild-type
embryos irradiated before the mid-blastula transition (MBT) underwent normal cell division until reaching the
MBT, after which they underwent massive, catastrophic apoptosis. Over-expression of Bcl-xL derived from XR11
females, but not males, provided partial protection from apoptosis. Maternal expression of XR11 was also
sufficient to abrogate apoptosis triggered by post-MBT γ-radiation. Tolerance to post-MBT γ-radiation from
zygotically-derived XR11 was acquired gradually after the MBT in spite of abundant XR11 protein synthesis.
Conclusion:  Our data suggest that Bcl-xL is an effective counterbalance to proapoptotic factors during
embryonic development but has no apparent effect on the thyroid hormone-induced apoptosis that occurs during
metamorphosis. Furthermore, post-MBT apoptosis triggered by irradiation before the MBT could only be
restrained by maternal expression of Bcl-xL. Although maternal expression of XR11 was sufficient to abrogate
apoptosis triggered by post-MBT γ-radiation, radiation tolerance from zygotically-derived XR11 was acquired
gradually, indicating that synthesis of XR11 protein is not sufficient to prevent apoptosis. Thus, repression of
radiation-induced apoptosis by overexpression of Bcl-xL during embryonic development depends upon the timing
of its expression and post-translational events that enable the protein to become effective.
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Background
Cell death is an essential and integral aspect of embryonic
development (for reviews, see [1-3]). The genome is pro-
grammed to eliminate certain cells or groups of cells at
particular times during development by a process called
"programmed cell death" (PCD) [4-6]. Well-known
examples of PCD during vertebrate development include
interdigital cell death and regression of the tail and gills
during amphibian metamorphosis [3]. Considerable PCD
also occurs in the central nervous system (CNS; for review,
see [7]), where as much as 85% of some neuronal popu-
lations may be lost by PCD during development [8-11].
One form of PCD is apoptosis, which is characterized by
membrane blebbing, nuclear and cytoplasmic shrinkage,
chromatin condensation and DNA fragmentation [12].
The detection of DNA fragmentation in dying cells utiliz-
ing the TUNEL (TdT-mediated dUTP nick end labeling)
assay provides the basis for a sensitive and specific in situ
measure of apoptosis.
The frog Xenopus laevis provides an excellent model system
for studying apoptosis during embryonic development.
The TUNEL assay has been used on whole-mounts and tis-
sue sections of Xenopus embryos to monitor spontaneous
developmental apoptosis [13,14]. Apoptosis also pro-
vides the means for the embryo to rid itself of cells dam-
aged by DNA-damaging agents, such as gamma radiation
[15]. Gamma radiation during embryonic development is
a threat to the viability of the embryo and to its potential
to develop into a healthy, functional adult organism.
Embryos have two alternative mechanisms to prevent
developmental abnormalities caused by irradiation: elim-
ination of damaged cells through apoptosis or repair of
the damaged DNA. Xenopus embryos undergo a dramatic
transition in their response to ionizing radiation coinci-
dent with the onset of gastrulation. Embryos irradiated
before gastrulation continue to cleave normally and
undergo an abrupt, catastrophic, comprehensive and syn-
chronous apoptosis of DNA-damaged cells after the mid-
blastula transition (MBT) using a maternally-derived
mechanism that does not require transcription [15-20]. In
contrast, cells in embryos irradiated after gastrulation
reportedly do not undergo apoptosis [17,19,20].
The induction of apoptosis is subject to both pro- and
anti-apoptotic cellular factors and is executed by cysteine
proteases called caspases after their activation from the
proenzyme state. The activation of caspases can be trig-
gered by cytochrome c release from the intermembrane
spaces of mitochondria through mitochondrial outer
membrane permeabilization [21-24]. Release of cyto-
chrome c, in turn, is regulated by members of the Bcl-2
family (for reviews, see [23,25,26]). Members of the Bcl-2
family serve a key regulatory role in apoptosis, acting as
either pro- or anti-apoptotic factors. Thus, the relative lev-
els of members with opposing functions can determine
whether cells live or die [27] (for review, see [26]). One of
the anti-apoptotic members of the Bcl-2 family is Bcl-xL,
which functions to inhibit apoptosis in situations in
which Bcl-2 does not suffice [28]. For example, bcl-2
knockout mice are viable as embryos [29,30] whereas bcl-
xL knockout mice die as embryos that exhibit massive cell
death in the nervous and hematopoietic systems [31].
Over-expression studies conducted both in vitro and in
vivo in mice indicate that Bcl-xL is also sufficient to promote
survival of embryonic neurons [32-34]. Similar results
have been obtained with chick embryonic neurons in vitro
[35]. Members of the Bcl family also modulate the apop-
togenic effects of DNA-damaging agents. For example,
lymphoid cells from bcl-2 null mice are hypersensitive to
irradiation in vitro [29,30]. Conversely, over-expression of
bcl-2 reduces the rate of apoptosis of γ-irradiated hemat-
opoietic cells both in vitro and in vivo [36,37].
Cruz-Reyes and Tata [38]cloned two bcl-related genes in
Xenopus laevis, which they designated as XR1 and XR11.
XR11 [GenBank:X82461], which most closely resembles
Bcl-xL, is expressed as early as stage 12 (gastrula) and con-
tinues to be expressed throughout embryonic, larval and
adult life. Over-expression of XR11 in Rat-1 fibroblasts
protected the cells from apoptosis, thus demonstrating
that XR11 is an anti-apoptotic member of the Bcl family.
Misexpression of human Bcl-2 or XR11 in Xenopus
embryos has been shown to impede developmental- or
chemically-induced apoptosis, respectively, during early
Xenopus laevis embryonic development [17,39]. The trans-
genesis technique developed by Kroll and Amaya [40]
provides the means to study the effects of genes on later
developmental events and to examine the effects of the
transgenes on subsequent generations. For example, Coen
et al. [41] employed a neuron-specific promoter driving
XR11 over-expression to demonstrate selective protection
of Rohon-Beard cells during metamorphosis. In this
report, we have used a constitutive promoter to examine
the effects of generalized XR11 over-expression through-
out Xenopus development and to examine the respective
roles of maternal and zygotic XR11 in protection against
γ-radiation-induced apoptosis during development.
Results
Over-expression of XR11 dramatically reduced 
spontaneous developmental apoptosis in embryos
Over-expression of XR11 in nuclear transplant embryos
was achieved by utilizing a plasmid containing colinear
CMVXR11 and CARGFP genes. CMV is a strong constitu-
tive promoter in Xenopus, whereas XCAR promotes gene
expression in muscle and cardiac tissue. Thus, XR11
should be expressed universally, whereas expression of
the colinear GFP reporter gene in muscle and heart was
used to select XR11 transgenics. To determine whether theBMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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over-expression of XR11 protected embryonic cells from
apoptosis, we compared the incidence of TUNEL-positive
nuclei between XR11 and control transgenic whole-
mount and sectioned tailbud-stage embryos. Yeo and
Gautier [39] demonstrated that the TUNEL assay is effec-
tive and specific for detecting apoptosis in Xenopus
embryos. Examination of control whole-mount tailbud-
stage embryos (Fig. 1A, C) showed that darkly labelled
apoptotic nuclei are particularly prevalent in the heads,
whereas XR11 transgenics (Fig. 1B, D) exhibited little or
no detectable apoptosis. Examination of cross-sections
(Fig. 2A) revealed that TUNEL-positive nuclei were most
prevalent in the retinas and brains, whereas XR11 trans-
genic embryos lack TUNEL-positive nuclei. Counts of
total TUNEL-positive nuclei in sections were made at
stages 28, 33/34, 37 and 41 (Fig. 2B). In GFP controls,
TUNEL-positive cells peaked at stage 33/34, whereas XR11
overexpressing embryos had nominal numbers of
TUNEL-positive nuclei at all stages. For example, over-
expression of XR11 at stage 33/34 reduced apoptosis by
95%. Student's t-tests indicate that the differences in the
numbers of TUNEL-positive nuclei between the XR11 and
GFP embryos are highly significant (p = 0.001 for stage 41
and 0.001 > p > 0.000 for stages 28, 33/34 and 37).
Over-expression of XR11 did not impede apoptosis that 
occurs during normal or thyroid hormone-induced 
metamorphosis
If pro-apoptotic factors facilitate apoptosis during meta-
morphosis of tadpoles into frogs, we would expect over-
expression of the anti-apoptotic XR11 to impede meta-
morphosis. However, XR11 transgenic tadpoles devel-
oped as apparently normal larvae that underwent
metamorphosis, losing their transient larval structures,
TUNEL assays on whole-mount tailbud-stage embryos at stages 28(A, B) and 33/34 (C, D) Figure 1
TUNEL assays on whole-mount tailbud-stage embryos at stages 28(A, B) and 33/34 (C, D). A, C: GFP transgenic 
embryos B, D: XR11 transgenic embryos.BMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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Comparisons of TUNEL-positive nuclei between GFP and XR11 transgenic embryos during embryonic development Figure 2
Comparisons of TUNEL-positive nuclei between GFP and XR11 transgenic embryos during embryonic devel-
opment. A. Cross-sections of embryos showing the distribution of TUNEL-positive nuclei at the level of the eye at stage 33. 
DAPI (blue) and TUNEL (red) images have been superimposed. Left: GFP transgenic embryo. R, retina; B, brain. Right: XR11 
transgenic embryo. Dorsal is at the top. B. Mean numbers of TUNEL-positive nuclei in sections at stages 28, 33/34, 37/38 and 
41. Error bars indicate standard error of the mean. Means were obtained by examining between 14 and 18 embryos for each 
category. A minimum of 4 and a maximum of 14 sections were examined for each embryo. Pooled data from multiple 
experiments.BMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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such as gills and tails (Fig. 3A, B). The loss of gills is evi-
dent by the slimming of the body profile in the
pharyngeal region (arrow in A). The remnant of the tail is
indicated by the arrow in B. Loss of these structures occurs
via apoptosis during metamorphosis in response to thy-
roid hormone [42].
To address more specifically whether apoptosis can be
triggered by thyroid hormone in XR11 transgenics, we
used the metamorphosis induction assay described by
Tata [43] and Huang et al. [44]. One-week tadpoles were
exposed to triiodothyronine (T3) for five days. As shown
in Figure 3C–J, tadpoles transgenic for XR11 displayed the
Metamorphosis of XR11 transgenic tadpoles and responses to exogenous thyroid hormone (T3) Figure 3
Metamorphosis of XR11 transgenic tadpoles and responses to exogenous thyroid hormone (T3). A, B. An XR11 
transgenic froglet undergoing metamorphosis. C-J. Responses of one-week old (approximately stage 45) transgenic tadpoles to 
thyroid hormone (T3). XR11 transgenic tadpoles (G-J;) display the same gross responses to 5 days exposure to as do GFP 
transgenics (C-F). C, E, G and I are live tadpoles, whereas D, F, H and J are fixed tadpoles stained with Alcian blue to reveal 
the skeleton and the gill apparatus. K-R. The apoptotic response of one-week old transgenic tadpoles (approximately stage 45) 
to T3 was assessed in cross-sections through the velum. DAPI staining (K, M, O and Q) reveals nuclei, whereas the TUNEL 
assay (L, N, P and R) distinguishes apoptotic nuclei. The velum of the GFP transgenic tadpole (M, N) has begun dissociating in 
response to T3 treatment. S. Demonstration of XR11 over-expression in tadpoles by immunoprecipitation. This experiment 
was repeated once.BMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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same gross responses to thyroid hormone, including gill
resorption, as shown by the GFP transgenics with no dis-
cernable delay. The gill apparatus, which is visible in the
absence of T3 (arrow in H), regresses after T3 treatment in
both cases. Meckel's cartilage (the lower jaw) shows a dra-
matic beak-like reshaping (arrows in F and J).
To determine whether apoptosis was occurring equally in
the GFP and XR11 transgenic tadpoles, we focused on the
ventral velum, a portion of the larval filter feeding appara-
tus that has a chevron shape in cross section before it dis-
sociates through apoptosis during metamorphosis [45].
As shown in Figure 3K–R, TUNEL-positive nuclei, which
are rare in the velums in the absence of T3, were prevalent
in the velums of both T3-treated GFP and XR11 transgenic
tadpoles. These results indicate that apoptosis that
occurred in response to thyroid hormone was unaffected
by over-expression of XR11. One possible explanation for
the extensive apoptosis in the XR11 transgenic tadpoles is
that the XR11 protein was no longer over-expressed. How-
ever, as shown in Figure 3S, immunoblotting with an anti-
body to XR11 confirmed that the 22 kDa XR11 protein
was over-expressed in the transgenic tadpoles. Proteins
were extracted from individual tadpoles at approximately
stage 45, separated by electrophoresis, blotted and probed
as described in Methods. These tadpoles had been treated
with triiodothyronine (T3). Similar results were obtained
with samples from untreated tadpoles (data not shown).
The variation in the GFP signal reflected the intensity of
GFP fluorescence in the live tadpoles, presumably reflect-
ing differences in the number of integrated copies of GFP.
The 22 kDa XR11 signal is considerably stronger in the
XR11 transgenic sample than in the GFP transgenic sam-
ple, reflecting XR11 transgene expression.
XR11 transgenic frogs are fertile and transmit the 
transgene
The failure of XR11 over-expression to prevent metamor-
phosis enabled us to rear the resultant frogs to sexual
maturity. We induced ovulation in adult females and used
the sperm from adult males to obtain second-generation
embryos overexpressing XR11. The results of representa-
tive crosses are shown in Table 1. Individual parents were
designated by number (i.e., XR11-01, XR11-02). Crossing
the XR11-01 male with a wild-type female gave a 1:1 ratio
of transgene positive to transgene negative progeny, sug-
gesting that his genome had integrated the transgene at a
single site. Crossing him with the XR11-01 female gave a
3:1 ratio, a result consistent with a single transgene
integration site. However, crossing him with the XR11-02
female yielded a 7:1 ratio, suggesting that this female had
two transgene integration sites.
Over-expression of XR11 curtailed apoptosis induced by 
irradiation
The ability to produce second-generation transgenics gave
us the opportunity to compare the effects of maternal and
zygotic expression of the XR11 transgene on susceptibility
of embryos to γ-radiation-induced apoptosis. Consistent
with the literature [15], wild-type embryos subjected to
-radiation before the MBT did not undergo apoptosis
before the MBT (data not shown). The appearance of
TUNEL-positive nuclei was delayed until after the MBT
and was radiation dosage-dependent (Fig. 4A–F). After
exposure to 10 Gy (Fig. 4B) blastopores were not evident,
and large sectors containing TUNEL-positive nuclei were
seen. More extensive damage was seen after exposure to
20 Gy (Fig. 4C). TUNEL-positive nuclei were pervasive.
Dissociation of the embryos was so extensive that the
embryos often fragmented during the TUNEL procedure.
In contrast to the results with wild-type embryos, embryos
produced by fertilization of eggs from XR11 females with
wild-type sperm showed evidence of partial protection
from γ-radiation (Fig. 4E, F). Reduced damage from radi-
ation was always observed after exposure to 10 Gy, but
protection from 20 Gy was variable from experiment to
experiment, suggesting that overexpression of XR11 was
not always sufficient to overcome the effects of 20 Gy.
To investigate whether protection from radiation-induced
damage was due to maternal or zygotic expression of the
transgene, we irradiated embryos derived from fertilizing
eggs of wild-type females with sperm from XR11 males
and compared them to wild-type embryos. If zygotic
expression of the transgene could partially overcome the
effects of pre-MBT γ-radiation, we would have expected to
see a subset of embryos with few or no TUNEL-positive
nuclei that resembled embryos derived from eggs of XR11
females. Instead, all embryos resembled irradiated wild-
Table 1: Representative Crosses Illustrating Inheritance of the XR11 Transgene
Cross GFP positive GFP negative Ratio (χ2)
XR11-01 male × WT-01 female 197 199 1:1 (p < 0.9)
XR11-01 male × XR11-01 female 319 90 3:1 (p < 0.1)
XR11-01 male × XR11-02 female 321 46 7:1 (p < 0.9)

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Maternal and paternal expression of the XR11 transgene Figure 4
Maternal and paternal expression of the XR11 transgene. A-F. Maternal expression of the XR11 transgene reduces the 
extent of apoptosis in embryos exposed to γ-radiation at stage 6–6.5 and examined 12 hours after irradiation by whole-mount 
TUNEL assays. A-C, Wild-type embryos. A, Representative control embryos. Arrow indicates the blastopore lip. No evidence 
of apoptosis is apparent. Embryos that had been exposed to 10 Gy are shown in B. More extensive damage is seen after expo-
sure to 20 Gy (C). D-F, TUNEL assays of progeny of fertilization of XR11 eggs by wild-type sperm after exposure to either 10 
Gy (E) or 20 Gy (F). This experiment was conducted three times using eggs from four XR11 females. G-L. Paternal expression 
of the XR11 transgene does not protect embryos from apoptosis induced by γ-radiation before the MBT. Representative 
whole-mount TUNEL assays comparing the effects of γ-radiation at stage 6–6.5 on wild-type embryos (G-I) and progeny of fer-
tilization of wild-type eggs by XR11 sperm (J-L). Embryos were fixed for TUNEL assay 12 hours after irradiation. G, J. Con-
trols. H, K. 10 Gy. I, L. 20 Gy. This experiment was conducted twice using sperm from two XR11 males.BMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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type embryos (compare Fig. 4J–L to Fig. 4G–I). Extensive
TUNEL-positive nuclei are seen in both groups at both
doses. Furthermore, the embryos exposed to 20 Gy frag-
mented during the TUNEL procedure. These results are
consistent with a requirement for a maternal source of
radiation protection at these early stages.
According to the literature, embryos irradiated after the
MBT do not undergo apoptosis [17,19,20]. Indeed,
embryos that were irradiated after the MBT (stage 11.5)
and examined 12 hours later did not show outward signs
of radiation damage (data not shown). However, TUNEL
assays showed that irradiation enhanced apoptosis in
wild-type embryos, predominantly in the brain, eyes,
pharynx and tail bud. Hence, we sought to determine
whether the maternal effect of the XR11 transgene was
sustained after the MBT and whether zygotic expression of
the transgene could also confer radiation tolerance. To do
this, we segregated the XR11 transgenic embryos of over-
expressing XR11 females from their non-transgenic sib-
lings based upon their expression of the GFP reporter gene
under control of the cardiac actin promoter. The GFP neg-
ative (GFP-) embryos had maternal expression of the
XR11 transgene but no zygotic expression, whereas the
GFP positive (GFP+) embryos had both maternal and
zygotic XR11 transgene expression. Results show that
maternal expression of the XR11 transgene protected
embryos irradiated at stage 11.5 even if they did not
express zygotic XR11. As shown in Figure 5A–F, neither
the GFP- nor the GFP+ embryos had extensive apoptosis
after irradiation, although some GFP- embryos demon-
strated some apoptosis in the hindbrain region, but not in
the tail tip (see Fig. 5C). When embryos were irradiated
during the mid-30 stages (late tail bud) and examined 12
hours later, the protection afforded by maternal expres-
sion of XR11 had diminished significantly in the head and
pharynx, although the tail tips were still protected (Fig.
5K, L, O and 5P). However, zygotic expression of XR11
was very effective in conferring global protection from
apoptosis (Fig. 5M, N, Q and 5R).
To examine the effects of zygotic XR11 transgene expres-
sion in the absence of maternal expression, we irradiated
stage 11.5 embryos derived from fertilizing eggs from
wild-type females with sperm from XR11 males. Progeny
were scored 12 hours later for GFP expression directed by
the cardiac actin promoter to confirm the presence of the
transgene. As shown in Figure 6A–F, there was extensive
apoptosis in both the heads, pharynges and tail tips of
irradiated neurula-stage embryos and no discernable dif-
ference in the levels of apoptosis observed between the
GFP-positive and GFP-negative embryos. Embryos that
received 20 Gy radiation (Figs. 6C, F) are stunted with
blunt heads, indicative of extensive developmental
defects. These results suggest that zygotic expression of the
transgene had little effect in preventing apoptosis at this
stage. However, when sibling embryos were irradiated in
the mid-30 stages and examined 12 hours later, the trans-
gene conferred global protection from apoptosis (Fig. 6G–
L). Note particularly the extensive apoptosis that is evi-
dent in the otic capsules (arrows in Fig. 6H) of irradiated
embryos lacking the transgene (Figs. 6H, I).
The TUNEL data presented above indicate that: (1) mater-
nal expression of the XR11 transgene reduces the amount
of apoptosis induced by γ-radiation during pre-MBT and
early post-MBT stages, (2) protection from apoptosis by
maternal transgene expression is sustained in the tail tip
after tissues in the head become susceptible to apoptosis
(irradiation in the mid-30 stages) and (3) radiation toler-
ance is acquired gradually after the MBT and is sufficient
to provide complete protection from apoptosis to
embryos irradiated in the mid-30 stages of development.
To correlate transgene expression with repression of radi-
ation-induced apoptosis, we monitored XR11 RNA
expression and protein levels (Fig. 7). Expression of XR11
at the RNA level in embryos was monitored by RT-PCR
with primers designed against the XR11 sequence. RT-PCR
was performed on first strand cDNA synthesized from
RNA isolated from pre-MBT (stage 7) and post MBT (stage
10.5 and mid-30 stages) wild-type embryos and embryos
derived from fertilizing eggs of two different XR11 females
with wild-type sperm and the fertilization of wild-type
eggs with XR11 sperm. As shown in Figure 7A, we
observed maternal XR11 transcripts in pre-MBT embryos
derived from transgenic females. On the contrary, there
was no evidence for expression of the XR11 transgene in
embryos derived from wild-type eggs fertilized by XR11
sperm. After the MBT, XR11 mRNA derived from both
maternal and paternal transgenes was evident. Immunob-
lots (Fig. 7B) indicated the presence of maternally-derived
XR11 protein and the accumulation of XR11 protein from
either maternal or paternal transgene expression after the
MBT.
Discussion
The application of technology to modify Xenopus geneti-
cally has created opportunities to conduct functional
analyses that are not readily achieved by other means. In
this study, we have used XR11 transgenics to examine the
role of Bcl-xL in suppressing apoptosis during embryonic
development, thyroid-hormone-induced metamorphosis
and in response to γ-radiation. Our ability to raise XR11
transgenic frogs to maturity has also given us the
opportunity to distinguish between maternal and zygotic
contributions of Bcl-xL to radiation protection.
This study supports the growing evidence in the literature
that Bcl-xL is sufficient to promote neuronal survival inBMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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Representative TUNEL assays showing (A-F) the sustained radiation tolerance of early post-MBT embryos and (G-R) the effects  of zygotic transgene expression in late post-MBT embryos derived from eggs of XR11 females Figure 5
Representative TUNEL assays showing (A-F) the sustained radiation tolerance of early post-MBT embryos and 
(G-R) the effects of zygotic transgene expression in late post-MBT embryos derived from eggs of XR11 
females. (A-F). Embryos were irradiated at stage 11.5 and fixed for TUNEL assay 12 hours later. A-C. GFP-negative embryos 
(lacking the XR11 transgene). A, Control. B, 10 Gy. C, 20 Gy. D-F. GFP-positive embryos (containing the XR11 transgene). D, 
Control. E, 10 Gy. F, 20 Gy. This experiment was conducted four times using eggs from six XR11 females. G-R. Embryos were 
irradiated in the mid-30 stages and fixed for TUNEL assay 12 hours later. G, H, K, L, O, P. GFP-negative embryos (lacking the 
XR11 transgene). G, H. Control. Small numbers of TUNEL-positive nuclei are evidence of spontaneous developmental apopto-
sis. K, L. 10 Gy. O, P. 20 Gy. I, J, M, N, Q, R. GFP-positive embryos (containing the XR11 transgene). I, J. Control. M, N. 10 
Gy. The ventral pigmentation in M is not due to TUNEL-positive nuclei. Q, R. 20 Gy. This experiment was conducted once 
using eggs from two XR11 females.BMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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mice and chicken embryos [32-35]. Our experiments
showed that the XR11 transgene could eliminate most
apoptosis in the developing Xenopus  nervous system,
including the brain and eyes. This result is consistent with
a model in which the execution of developmental apopto-
sis is dependent upon a balance between pro-and anti-
apoptotic factors with Bcl-xL being one of the anti-apop-
totic factors. In spite of the abatement of developmental
apoptosis in XR11 transgenic embryos, there were no
apparent gross developmental consequences; the embryos
developed into phenotypically normal tadpoles. This
result suggests that developmental apoptosis is not
essential for development of vital organ systems, notably
the central nervous system, and that embryos can adapt to
an overabundance of neurons. However, detailed mor-
phometric studies would be necessary to confirm this con-
Representative TUNEL assays showing the effects of zygotic XR11 expression on radiation tolerance of (A-F) early post-MBT  embryos and (G-L) late post-MBT embryos derived from eggs of wild-type females Figure 6
Representative TUNEL assays showing the effects of zygotic XR11 expression on radiation tolerance of (A-F) 
early post-MBT embryos and (G-L) late post-MBT embryos derived from eggs of wild-type females. A-F. 
Embryos were irradiated at stage 11.5 and fixed for TUNEL assay 12 hours later. A-C. GFP-negative embryos. A. Control. B. 
10 Gy. C. 20 Gy. D-F. GFP-positive embryos (containing the XR11 transgene). D. Control. E, 10 Gy. F. 20 Gy. This experiment 
was conducted three times using sperm from five XR11 males. G-L. Embryos were irradiated in the mid-30 stages and fixed for 
TUNEL assay 12 hours later. G-I. GFP-negative embryos. G. Control. H. 10 Gy. I. 20 Gy. J-L. GFP-positive embryos (contain-
ing the XR11 transgene). J. Control. K. 10 Gy. L. 20 Gy. This experiment was conducted once using sperm from two XR11 
males. The experiment could not be repeated due to the unavailability of additional XR11 males.BMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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clusion. Yeo and Gautier [39] previously showed that
injection of human bcl-2 mRNA abrogated programmed
cell death during early Xenopus development, resulting in
an expansion of neural tissue and variations in the pat-
terns of expression of a number of genes expressed during
early neurogenesis. We did not examine gene expression
patterns in our embryos. However, if such alterations did
occur, they had no apparent functional consequences.
Contrary to expectation, metamorphosis of XR11 trans-
genic tadpoles was normal, as was the response to exoge-
nous thyroid hormone. If over-expression of Bcl-xL had
hindered metamorphosis, it would have indicated that
thyroid hormone triggers apoptosis by shifting the bal-
ance between pro-apoptotic factors and Bcl-xL. However,
this proved not to be the case, even though we found that
Bcl-xL was still misexpressed at metamorphosis. One pos-
sibility is that other members of the Bcl-2 family counter
apoptosis during these later stages. Another possibility for
the failure of XR11 transgenesis to prevent apoptosis dur-
ing metamorphosis is that expression of the transgene was
insufficient to shift the balance between pro-and anti-
apoptotic factors sufficiently to prevent apoptosis. It is
also possible that subtle changes in the timing, rate or cel-
lular selectivity of metamorphosis did occur that we failed
to detect. For example, Coen et al. [41] demonstrated
selective protection of Rohon-Beard neurons in XR11
over-expressing tadpoles during metamorphosis. We did
not assess cell-specific neoronal survival during
metamorphosis.
Upon reaching sexual maturity, both male and female
frogs were fertile. Crosses of transgenic frogs indicated
that most had small numbers of transgene integration
sites. This result was consistent with a previous transgene
transmission study [46]. The ability to produce second
generation transgenic XR11 embryos provided us with the
opportunity to examine both the maternal and zygotic
contributions of Bcl-xL to the apoptotic response to γ-radi-
ation. This provided evidence for a significant role for
apoptotic factor balance in determining whether cells that
had received damaging dosages of radiation during devel-
opment were eliminated. Other Bcl-2 family members
may carry out similar roles in that microinjection of
human Bcl-2 mRNA into Xenopus embryos is effective in
inhibiting irradiation-induced apoptosis [16].
Maternal and zygotic XR11 RNA expression and protein levels Figure 7
Maternal and zygotic XR11 RNA expression and protein levels. A. Over-expression of XR11 at the RNA level. RT-
PCR of the constitutively expressed elongation factor 1-alpha (EF1α) was conducted in parallel as a control. This experiment 
was conducted once. B. XR11 protein levels in pre- and post-MBT embryos were demonstrated by Western blot analysis. 
Because the XR11 protein is membrane-bound, it is difficult to separate it from yolk, which is abundant in embryos. The pres-
ence of yolk during electrophoresis results in wavy bands in the gel. This experiment was repeated once.BMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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Expression of the XR11 transgene had a profound effect
on whether cells of irradiated embryos underwent apop-
tosis. Furthermore, the application of transgenics allowed
us to demonstrate that this effect depended upon the
source of the over-expressed protein. Over-expression of
Bcl-xL derived from XR11 females provided partial protec-
tion from the normal massive apoptosis that occurs in
irradiated pre-MBT wild-type embryos after reaching the
MBT. However, if the XR11 gene was derived from XR11
males, no protection was seen. This result demonstrates
conclusively that apoptosis triggered by irradiation before
the MBT can be restrained by maternal expression of Bcl-
xL and that zygotic expression of Bcl-xL is ineffective in
overcoming the effects of prior irradiation.
Irradiation soon after the MBT (at stage 11.5) had much
more subtle effects on embryos. In wild-type embryos,
apoptosis was enhanced in the brain, eyes, pharynx and
tail tip. However, maternal expression of XR11 was suffi-
cient to abrogate apoptosis. Interestingly, zygotic expres-
sion of XR11 at this time was not effective in preventing
apoptosis even though XR11 protein was abundant at the
time of irradiation. The failure of zygotically-derived
XR11 to provide protection from apoptosis implies that
synthesis of XR11 protein is not sufficient to prevent
apoptosis.
Embryos irradiated during the mid-30 stages of develop-
ment revealed that the maternal effect conferring
protection from radiation-induced apoptosis had dimin-
ished significantly in the head and pharynx but persisted
in the tails. It will be interesting to learn whether the dif-
ference between the heads and tails is due to preferential
distribution or stability of maternal XR11 protein itself or
is due to auxiliary factors that influence XR11 protein
function. Bcl-xL and other members of the Bcl-2 family are
known to be subject to post-translational regulation by
such events as phosphorylation, proteolysis, cleavage,
protein-protein interactions and subcellular localization
[47,48]. Intriguingly, at these later stages, zygotic XR11
protein conferred global radiation protection. Thus, the
initial lack of functionality of zygotic XR11 protein that
we observed after the MBT had been overcome.
Biologically, the responses to irradiation after the MBT are
probably more significant than the universal, catastrophic
apoptosis that occurs in embryos irradiated before the
MBT. Failure to eliminate cells mutagenized by irradiation
would result in retention of cells that may have functional
deficiencies and have the potential to become malignant
due to genetic damage. Thus, the mechanisms that control
apoptosis in response to DNA damage have important
adaptive significance. Radiotherapy and a number of
chemicals have been shown to damage DNA and induce
apoptosis in mammals; this property has been exploited
in the clinic to induce apoptosis of cancer cells. Resistance
to apoptosis has important implications for the efficacy of
chemotherapy and radiotherapy because tumor cells that
overexpress either bcl-2 or bcl-xL may be resistant to either
mode of cancer therapy [37,49-52]. On the other hand,
their over-expression in non-tumor cells could enhance
the ability of these cells to survive the otherwise lethal
effects of radiation and chemotherapy.
Our results indicate that synthesis of Bcl-xL is not suffi-
cient to confer radiation protection; rather, it belatedly
acquires functionality. Possible explanations for the fail-
ure of Bcl-xL synthesized after the MBT to protect against
apoptosis could include the absence of posttranslational
modifications to the protein or the lack of a cooperative
factor that is necessary for the protein to function effec-
tively. The presence of this mechanism that confers func-
tionality on Bcl-xL protein before the MBT and its absence
soon after the MBT may provide an assay system that
would facilitate its identification. The discovery of a
mechanism that could control whether cells undergo
apoptosis after exposure to an apoptogenic stimulus
could have important implications for improving the effi-
cacy of chemotherapy and radiotherapy.
Conclusion
Our results are consistent with a model in which the exe-
cution of developmental apoptosis in embryos is depend-
ent upon a balance between pro-and anti-apoptotic
factors with Bcl-xL being one of the anti-apoptotic factors.
The drastic reduction of apoptosis in XR11 transgenic
embryos had no apparent functional consequences. Met-
amorphosis of transgenic tadpoles was apparently nor-
mal, as was the response to exogenous thyroid hormone.
The ability to produce second-generation transgenic XR11
embryos enabled us to examine both the maternal and
zygotic contributions of Bcl-xL to the apoptotic response
to γ-radiation. Post-MBT apoptosis that was triggered by
irradiation before the MBT was restrained by maternal
expression of Bcl-xL. However, zygotic expression of Bcl-xL
was ineffective in overcoming the effects of prior irradia-
tion. Maternal expression of XR11 was also sufficient to
abrogate apoptosis triggered by post-MBT γ-radiation.
However, zygotic expression of XR11 at this time was not




Adult Xenopus laevis were maintained in compliance with
the University of Calgary guidelines for animal care. Our
transgenesis protocol is based upon the technique
described by Sparrow[53], which is a simplification of the
procedure described by Kroll and Amaya [40]. The simpli-
fied technique eliminates the need to use egg extract andBMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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restriction enzyme to facilitate transgenesis. We have
found no significant difference in the frequencies of either
normal development, transgenesis or viability of
embryos, tadpoles or frogs using these two techniques
(data not shown). The simplified transgenic reaction
involves mixing 2.5 × 105 nuclei in 2.5 µl of sperm storage
buffer, 100 ng linearized DNA in 2.5 µl of water. The com-
ponents are mixed and left for 10 minutes at room tem-
perature (~20–23°C). At this point, 495 µl of sperm
dilution buffer is added, and the suspension is mixed gen-
tly and thoroughly before loading into microinjection
needles for nuclear transplantation. Nuclear transplant
embryos were screened for expression of the transgene by
detecting GFP fluorescence using an Olympus SZX9 fluo-
rescent stereomicroscope.
Tadpole husbandry
Tadpoles were fed Sera Micron http://www.sera.de/eng
lish/produkte/micron.htm, which is a fine granulated
tropical fish food. This proved to be an excellent diet for
tadpoles, which were maintained on it until metamor-
phosis. After metamorphosis, froglets were fed progres-
sively larger forms of NASCO Frog Brittle. Tadpoles were
either maintained in plastic food containers in which
water was changed manually as needed or in continuously
circulating Z-MOD tanks (Marine Biotech, Beverly, MA).
After metamorphosis, frogs were maintained in Z-MOD
tanks until they became large enough to be transferred to
larger-sized X-MOD tanks.
RNA purification
Whole tadpoles were homogenized in 100 µl TRIZOL
(Invitrogen), and 400µl of the reagent were added to the
homogenate. After incubation for 5 min at room temper-
ature, 100µl of chloroform were added, the mixture was
shaken vigorously for 15 seconds, incubated for 2–3 min-
utes at room temperature and centrifuged at 12,000 × g for
15 minutes at 4°C. 250 µl of isopropanol were added to
the supernatant, which was then incubated for 10 minutes
at room temperature and centrifuged at 12,000 × g for 10
minutes at 4°C. The supernatant was removed, and 500 µl
of 75% ethanol were added to the pellet. After mixing
well, the mixture was centrifuged at 7,500 × g for 5 min-
utes at 4°C. The supernatant was discarded, and the pellet
was air-dried. The dried pellet was rehydrated in RNase-
free water and stored at -80°C. Any contaminating DNA
was removed with DNA-free (Ambion) according to the
manufacturer's protocol. RNA concentration was deter-
mined by spectrophotometry at 260 nm.
RT-PCR
Ready-to-Go RT-PCR beads (Amersham Pharmacia) were
used according to the manufacturer's instructions for one-
step reactions. RT-PCR reactions for XR11 and EF1α were
run in tandem. 500 ng total RNA and 10 pmoles XR11
primers or 5 pmoles EF1α primers were used in each 50
ml reaction. The first strand reaction ran for 15 minutes
followed by a 5 minute incubation at 95°C The PCR step
ran for 35 cycles for the XR11 product or 30 cycles for the
EF1α product. Each cycle was 94°C for 1 minute, fol-
lowed by 55°C for 1 minute and 72°C for 1 minute. The
reaction was stopped by reducing the temperature to 4°C.
If necessary, the reaction products could be stored at -
20°C until analyzed. The PCR products were analyzed by
applying 10 µl samples to a 1.5%agarose/TAE gel contain-
ing 0.25 µg ethidium bromide (Sigma-Aldrich) in parallel
with a 100 bp ladder (Amersham Pharmacia).
EF1α-downstream primer: ACTGCCTTGATGACTCCTAG
EF1α-upstream primer: CAGATTGGTGCTGGATATGC
This primer pair will generate a 270 bp band.
XR11-downstream primer: GGCATTCTTTCCATACAGGC
XR11-upstream primer: CCTTCTACTTCAGAGCGCCC
This primer pair will generate a 400 bp band.
Immunoblotting
Antiserum to XR11 was prepared by Alpha Diagnostics
International, Inc. (San Antonio TX) in rabbit against a
synthetic peptide encompassing amino acids 11–30 (KFV
SKK LSQ NEA CRK FSN NP). This antiserum was used for
immunoblotting at a dilution of 1:1000. Secondary anti-
body was goat anti-rabbit conjugated to alkaline phos-
phatase (Jackson ImmunoResearch), which was used at a
dilution of 1:1000.
Individual embryos were homogenized so as to correlate
immunoblot results with GFP expression levels. Proteins
in tissue homogenates were separated using 15% SDS-
polyacrylamide gel electrophoresis and blotted onto
PVDF. Blots were blocked either overnight at 4°C or for
1.5 hours at room temperature in 5% skim milk powder
in TBS containing 0.1% Tween 20. The blots were then
incubated with the primary antibody in TBS containing
0.1% Tween 20 for 1 to 2.5 hr at room temperature,
washed 1 × 15 min and 3 × 5 min in TBS containing
0.1%Tween 20. The blots were then incubated with the
conjugated secondary antibody in TBS containing 0.1%
Tween 20 for 1 hr at room temperature, washed as
described above, rinsed with TBS, then with staining
buffer without stain reagents, followed by staining with
NBT/BCIP until developed.
Embryo whole-mount TUNEL assays
Pigmented embryos were collected at stages 28, 33, 37,
and 41 and processed for TUNEL assays as described byBMC Developmental Biology 2005, 5:20 http://www.biomedcentral.com/1471-213X/5/20
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Hensey and Gautier [13]. After staining, the embryos were
fixed while rocking overnight at room temperature in
Bouin's solution (70 ml water, 25 ml 37% formaldehyde,
5 ml glacial acetic acid). Embryos were then washed (four
times for 15 minutes each) in TE buffered ethanol.
Embryos were then bleached for 1 hour at room tempera-
ture in 0.5 × SSC, 5% formamide, 1%H2O2 in a Petri dish
on a piece of aluminum foil on a shaker under a fluores-
cent lamp, washed twice for 5 min each in methanol and
cleared in BB/BA (2:1 benzylbenzoate:benzyl alcohol).
Photographs were taken of embryos representative of the
extremes of TUNEL-positive nuclei.
Cryosectioning
Samples were collected at the appropriate stages and fixed
overnight at 4°C in MEMFA (0.1 M MOPS pH 7.4, 2 mM
EGTA, 1 mM MgSO4, 3.7 % formaldehyde). Samples were
then embedded in OCT Compound (Tissue Tek Cat
#4583). The embedded samples could then either be
stored at -80°C or sectioned immediately. 14 µm sections
were made using a Microm cryostat with cabin tempera-
ture set at -12°C. Sections were stored at -20°C if not
processed immediately. Sections were processed using the
ApoTagRed  in situ Apoptosis Detection Kit, catalogue
#7165 according to the manufacturer's protocol (Intergen
Co., Purchase NY). Sections were visualized using a Zeiss
Axioplan 2 microscope with Spot camera and software.
Induced metamorphosis
3,3',5-Triiodo-L-thyronine (T3; Sigma Cat #T2752) was
added one week after fertilization to a final concentration
of 10 nM to tadpole water and changed daily for the dura-
tion of the experiment [44](Huang et al., 1999). Before
and during treatment, tadpoles were maintained in 0.1 ×
MMR (for description, see Kroll and Amaya [40]) in the
absence of food. Tadpoles responded uniformly to the
hormone.
Cartilage staining
Cartilage was visualized in tadpoles according to the pro-
cedure described by Klymkowsky and Hanken [54]. Tad-
poles were anesthetized in 0.02% benzocaine and
immersed in 0.02% Alcian blue 8GX in 70% ethanol/30%
glacial acetic acid. After staining, tadpoles were passed
through an ethanol series (100, 100, 95, 70, 40, 15%) and
then into distilled water. They were then washed in two
changes of methanol and cleared in BB/BA.
Irradiation of embryos
Embryos to be irradiated were placed in ~2.5 ml 0.1 ×
MMR in 35 × 10 mm plastic Petri dishes (approx. 20/dish)
and exposed to either 10 Gy or 20 Gy from a Cesium 137
source in a Gammacell 1000 irradiation chamber (MDS
Nordion International Inc., Ottawa, ON Canada). After
irradiation, embryos were transferred to 60 × 10 mm plas-
tic Petri dishes containing 0.1 × MMR and allowed to
recover for 12 hours at room temperature. Unless noted
otherwise, each experiment was repeated at least once.
List of abbreviations
DAPI: 4',6-diamidino-2-phenylindole dihydrochloride
GFP: green fluorescent protein
MBT: Mid-blastula transition
NBT: Nitroblue tetrazolium
PCD: programmed cell death
SSC: sodium chloride/sodium citrate
T3: 3,3',5-triiodothyronine
TBS: Tris-buffered saline
TAE: 40 mM Tris-acetate and 1 mM EDTA
TE: 10 mM Tris-HCl and 1 mM EDTA
TUNEL: TdT-mediated dUTP digoxigenin nick end
labeling
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